公告日期：2026-05-30

Stock Code: 600873 Stock Abbreviation: Meihua Bio
Meihua Holdings Group Co., Ltd.

Annual Report 2025

This is an English translation from the Annual Report 2025, in case of

any inconsistency, the Chinese Version shall prevail.

Important Information

I. The Company’s board of directors, directors, and officers guarantee that the contents of this
annual report are true, accurate, and complete without any false records, misleading statements,
or material omissions and bear joint and several legal liability.

II. All of the Company’s directors have attended the board meeting.

III. RSM China CPA LLP (Special General Partnership) has issued an unqualified audit report
for the Company.

IV. Wang Aijun, the principal of the Company, Wang Lihong, the accounting principal, and
Wang Ailing, the principal of the accounting body (the accounting officer), hereby declare that
they guarantee the truthfulness, accuracy, and completeness of the financial report in the annual
report.

V. Profit distribution plan or capital reserve conversion plan for the Reporting Period as
approved by the Board

Upon deliberation and approval of the 2nd meeting of the 11th session of the board of directors, the
profit distribution plan (proposal) for 2025 is as follows: The Company plans to distribute cash
dividends based on the total share capital registered on the equity distribution record date (after
deducting shares in the share repurchase account). A cash dividend of 0.4279 yuan per share (inclusive
of tax) will be distributed to all shareholders. As of December 31, 2025, the Company had a total share
capital of 2,804,241,650 shares, based on which the estimated total cash dividend distribution amounts
to 1,199,935,002.04 yuan (inclusive of tax).

The plan is yet to be submitted to the general meeting for deliberation. The amount that is actually
distributed will be……
[点击查看PDF原文]

提示：本网不保证其真实性和客观性，一切有关该股的有效信息，以交易所的公告为准，敬请投资者注意风险。